Unsafe injections rejected as major source of HIV infection in Africa (p 482)February 04, 2004A recent theory proposing that unsafe injections are a major cause of HIV-1 infection in sub-Saharan Africa is rejected by authors of an article in this week's issue of THE LANCET. During the past year, a group (D Gisselquist and colleagues) has argued that unsafe injections are a major mode of HIV-1 transmission in sub-Saharan Africa, with up to 40% of HIV-1 infections being attributed to unsafe injections. In this week's issue of THE LANCET, an international group of experts* has identified and reviewed the main arguments used to question the conventional view that unsafe sex is overwhelmingly the leading mode of HIV-1 transmission. The authors state that although there is a clear need to eliminate all unsafe injections, epidemiological evidence indicates that sexual transmission continues to be by far the major mode of spread of HIV-1. The authors base their conclusions on a number of observations. A major flaw in the Gisselquist theory, they state, is that in sub-Saharan Africa unsafe intramuscular injections (defined as the reuse of needles/syringes in the absence of proper sterilization) are not as frequent as alleged. Further, they state, needles and syringes are uncommonly contaminated by blood after use (and are rarely contaminated by HIV, even after use on HIV-positive individuals) and the common practice of washing and heating of reused needles and syringes efficiently destroys HIV. The authors also include arguments that HIV-1 infection in children (who are not sexually active) is uncommon, that patterns of injection use do not correlate well with HIV incidence, that individuals who are initially HIV-negative but at a later date are found to be HIV-positive do not have substantially different histories of injections than those who did not become HIV-positive, that association is not the same as causation, and that high rates of other sexually transmitted infections in Africa are compatible with frequent sexual transmission of HIV. Lead author George Schmid from the World Health Organization (WHO) comments: "Analysis of studies published by Gisselquist and colleagues provides no compelling evidence that unsafe injections are a major mode of HIV-1 transmission in sub-Saharan Africa. We agree, however, that unsafe injections are an unacceptable practice and that efforts should be increased to reduce exposure of patients to any bloodborne infection in health-care settings." The authors also noted that improved data are needed to identify these risks, and that research should focus not just on the formal health-care system (both public and private), but also on the informal health-care system, eg. practices of traditional healers. The authors concluded: "epidemiological evidence indicates that sexual transmission continues to be the major mode of spread of HIV-1 in Africa." *Institutions of authors: World Health Organization, Geneva; United Nations Joint Programme on AIDS, Geneva; Institute of Tropical Medicine, Antwerp; Joint Clinical Research Centre, Kampala; Imperial College, London; London School of Hygiene and Tropical Medicine, London; Centers for Disease Control and Prevention, Atlanta, GA; Harvard School of Public Health, Boston, MA; Yale University School of Medicine, New Haven, CT. | |||||||||||||||||||||
|
Related HIV Current Events and HIV News Articles Study sheds light on causes of HIV dementia A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications. New HIV film tackles stigma faced by teachers in Africa Addressing the discrimination against HIV-positive teachers in Africa is a key aim of a new documentary and accompanying book being launched in Senegal today by the Partnership for Child Development based at Imperial College London. Selenium may slow march of AIDS Increasing the production of naturally occurring proteins that contain selenium in human blood cells slows down multiplication of the AIDS virus, according to biochemists. ACP recommends routine HIV screening for all patients On World AIDS Day, the American College of Physicians (ACP) is giving doctors a call-to-action to routinely encourage HIV screening to all of their patients older than 13 years. This new practice guideline appears on the Annals of Internal Medicine Web site at www.annals.org. Study of ancient and modern plagues finds common features In 430 B.C., a new and deadly disease-its cause remains a mystery-swept into Athens. The walled Greek city-state was teeming with citizens, soldiers and refugees of the war then raging between Athens and Sparta. Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models. UT Southwestern researchers develop new strategy for broad spectrum anti-viral drugs Bavituximab, an anti-viral drug developed by UT Southwestern Medical Center researchers, shows promise as a new strategy to fight viral diseases, including potential bioterrorism agents. More at-risk teens and young adults engaging in anal intercourse A new study by researchers at the Bradley Hasbro Children's Research Center suggests that the incidence of heterosexual anal sex is increasing among teens and young adults - particularly those who have recently had unprotected vaginal sex. Landmark study defines benefits of early HIV testing and treatment for infected infants Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the New England Journal of Medicine. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. More HIV Current Events and HIV News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||